文献速递重症综合管理与镇静镇痛创伤与烧伤

脑死亡器官捐献者的激素替代治疗:以创伤性脑损伤为重点的综合综述

Hormone replacement therapy in brain-dead organ donors: a comprehensive review with an emphasis on traumatic brain injury.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论综述显示93%的研究中激素替代治疗与器官获取率显著增加相关,但现有证据仅为III/IV级,需I/II级研究确定最佳实践。

本文为综合综述,检索脑死亡器官捐献者激素替代治疗(HRT)相关文献,最终纳入15项III级或IV级证据研究。甲状腺激素、胰岛素和糖皮质激素联合是最常被引用的HRT方案;93%的研究发现接受HRT的捐献者器官获取率显著增加。8项研究在脑死亡宣告后给药,仅2项专门探讨更早启动HRT并发现获取率更高;4项研究专门针对创伤性脑损伤(TBI),其余11项研究中TBI占样本的22%至89%。作者结论认为现有文献报告了令人信服的结果,但仍需进一步I级和II级证据研究以确定最佳实践。

要点

  • 纳入的15项研究中93%报告接受HRT的脑死亡捐献者器官获取率显著增加,证据级别为III级或IV级。
  • 甲状腺激素、胰岛素和糖皮质激素联合是最常被引用的HRT方案。
  • 8项研究在脑死亡宣告后给予HRT,仅2项专门探讨更早启动HRT并发现器官获取率更高。
  • 4项研究专门针对TBI,其余11项研究中TBI占样本22%至89%。
  • 作者认为现有文献结果令人信服,但仍需进一步I级和II级证据研究以确定最佳实践。

适用人群与场景

  • 脑死亡器官捐献者,尤其是因严重脑损伤(包括创伤性脑损伤)导致脑死亡者。
  • 排除标准:非英文研究、非人体研究、样本量小(病例报告或少于5例的病例系列)。

处置流程与药物剂量

  • 8项研究在脑死亡宣告后给予HRT;仅2项研究专门探讨更早启动HRT并发现器官获取率更高。

研究设计与关键结果

  • 研究类型:综合综述;共纳入15项研究,证据级别为III级或IV级。
  • 93%的研究发现接受HRT的捐献者器官获取率显著增加。
  • 4项研究专门针对TBI,其余11项研究中TBI占样本的22%至89%。
  • 8项研究在脑死亡宣告后给予HRT;仅2项研究专门探讨更早启动HRT并发现获取率更高。
  • 作者结论:现有文献报告了令人信服的结果,但仍需进一步I级和II级证据研究以确定最佳实践。

证据类型、等级与局限

  • 证据类型:综述文章,证据级别为IV级;纳入研究包含III级或IV级证据。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,针对脑死亡相关的内分泌紊乱(尤其是TBI后),供者管理包括HRT已被提出;现有文献报告了令人信服的结果,但仍需进一步I级和II级证据研究以确定最佳实践。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Organ shortage is an ongoing problem in the United States. Most donor organs are procured following brain death and a significant portion of brain-dead donors result from devastating brain injury. Without a standard practice for hormone replacement therapy (HRT) in the setting of brain death, a comprehensive review of the literature was deemed necessary.

METHODS: A search of published literature was conducted with terms "TBI" or "brain injury" or "head injury" AND "hormone" or "management" AND "organ" AND "donor" or "donation." Abstracts and full texts were screened for relevance and inclusion of information on HRT. Additional studies were selected from references cited within these. Excluded studies were non-English, nonhuman based, or had small sample size, (i.e., case reports or series with fewer than five subjects).

RESULTS: Fifteen studies were selected for inclusion and contained Level III or Level IV evidence. Combinations of thyroid hormone, insulin, and corticosteroids were the most commonly cited HRT. Ninety-three percent of studies found a significant increase in organ procurement rate among donors who received HRT. Hormone replacement therapy was administered after brain death declaration in eight studies. Only two studies specifically explored the effects of starting HRT earlier and identified even greater procurement rates. Four studies were specific to traumatic brain injury (TBI); the remaining 11 studies involved TBI in 22% to 89% of the sample.

CONCLUSION: Organ shortage remains a growing problem in the United States. Donor management including HRT has been proposed to combat the endocrine derangement associated with brain death and, in particular, TBI. While the existing literature reported compelling outcomes using HRT, there remains a need for further Level I and Level II evidence studies to define optimal practice.

LEVEL OF EVIDENCE: Review article, level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Turco LM, Glorsky SL, Winfield RD, et al. Hormone replacement therapy in brain-dead organ donors: a comprehensive review with an emphasis on traumatic brain injury. J Trauma Acute Care Surg. 2019. PMID: 30629014. doi:10.1097/TA.0000000000002187

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。